Kentaro Iwaki

Kentaro Iwaki

Auto-generated profile, based on publicly available information

Kentaro Iwaki

Department of Surgery I, Oita University Faculty of Medicine, Oita, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2007 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
KIKentaro Iwaki
Kentaro Iwaki
KSKohei Shibata
Kohei Shibata
MOMasayuki Ohta
Masayuki Ohta
YEYuichi Endo
Yuichi Endo
HUHiroki Uchida
Hiroki Uchida
SKSeigo Kitano
Seigo Kitano
Proteinase‐activated receptor‐2 (PAR‐2), which is a G protein‐coupled receptor, is activated in inflammatory processes and cell proliferation. We previously demonstrated that an anti‐PAR‐2 antibody suppresses proliferation of human pancreatic cellsin vitro. However, there have been no studies of PAR‐2 signaling pathwaysin vivo. The aim of this study was to determine whether blockade of PAR‐2 by RNA interference influences pancreatic tumor growth. We originally constructed small interfering RNAs (siRNAs) targeting humanPAR‐2, and performed cell proliferation assays of Panc1 human pancreatic cancer cell line with these siRNAs. Intratumoral treatment with these PAR‐2 siRNAs and atelocollagen was also performed in a xenograft model with nude mice and Panc1 cells. siRNAs against humanPAR‐2inhibited proliferation of Panc1 cells, whereas control scramble siRNAs had no effect on proliferation. The PAR‐2 siRNAs dramatically suppressed tumor growth in the xenograft model. PAR‐2‐specific siRNA inhibited growth of human pancreatic cancer cells bothin vitroandin vivo. Blockade of PAR‐2 signaling by siRNA may be a novel strategy to treat pancreatic cancer.

19 September 2009
Verified
Journal Article
Closed access
HUHiroki Uchida
Hiroki Uchida
KSKohei Shibata
Kohei Shibata
KIKentaro Iwaki
Kentaro Iwaki
SKSeiichiro Kai
Seiichiro Kai
MOMasayuki Ohta
Masayuki Ohta
SKSeigo Kitano
Seigo Kitano

1 January 2008 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Closed access
PDF file
MOMasayuki Ohta
Masayuki Ohta
SKSeigo Kitano
Seigo Kitano
SKSeiichiro Kai
Seiichiro Kai
YEYuichi Endo
Yuichi Endo
HEHidetoshi Eguchi
Hidetoshi Eguchi
KSKohei Shibata
Kohei Shibata
はじめに: 我々が我が国に導入した腹腔鏡下調節性胃バンディング術 (laparoscopic adjustable gastric banding; 以下, LAGB) の体重減少効果と肥満関連健康障害に対する改善効果について検討したので報告する. 方法: 2005年8月からの2年間に21例の内科治療無効の肥満症例にLAGBを施行した. 平均年齢38歳, BMI 44kg/m2であり, 肥満関連健康障害を平均3.1疾患有していた. LAGBは全例, Pars flaccida法で行い, バンドの逸脱予防のために胃-胃縫合を3~5針行った. 結果 LAGBの周術期に1例も合併症を認めず, 術後の平均在院期間は平均3.4日であった. LAGB後の平均体重減少は12か月25kg, 18か月29kgであり, 過剰体重減少率は12か月41%, 18か月49%であった. 良好な体重減少により, 高血圧91%, 高脂血症94%, 糖尿病100%と高率に改善した. 考察: LAGBは安全性と有効性を兼ね備えた術式であり, 今後我が国においても普及していくものと思われた.

1 June 2007
Verified
Journal Article
Closed access
XFXiao Yan Fan
Xiao Yan Fan
HUHiroki Uchida
Hiroki Uchida
KIKentaro Iwaki
Kentaro Iwaki
SKSeiichiro Kai
Seiichiro Kai
KSKohei Shibata
Kohei Shibata
SKSeigo Kitano
Seigo Kitano

1 January 2008 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Closed access
PDF file
TMTakashi Masuda
Takashi Masuda
HUHiroki Uchida
Hiroki Uchida
KIKentaro Iwaki
Kentaro Iwaki
HEHidetoshi Eguchi
Hidetoshi Eguchi
YEYuichi Endo
Yuichi Endo
SKSeigo Kitano
Seigo Kitano
症例は53歳の女性で, 健診の18F-fluorodeoxyglucose positron emission tomographyにて肝外側区域に異常集積を示す腫瘍性病変を指摘され精査目的に当科紹介となった. 胆嚢結石症, 総胆管結石症, 急性膵炎に対する治療歴があった. 腹部造影CTでは, 肝S3に辺縁がリング状に造影され, 内部が低吸収を呈する境界不明瞭な3cm大の腫瘍性病変を認めた. 発熱などの炎症症状なく, 臨床経過および画像検査所見より肝内胆管癌と術前診断し, 肝外側区域切除術を施行した. 切除標本では, 境界明瞭な淡黄白色の硬い腫瘤を認め, 肉眼的にも肝内胆管癌が疑われた. しかし, 組織検査所見では腫瘍細胞は認めず, 好中球浸潤の目立つ急性・慢性炎症性細胞と線維芽細胞, 線維化からなるmicroabscessの像であり, granulomatous abscessと診断した. 胆道の手術既往がある症例などには肝内胆管癌の鑑別診断に肝granulomatous abscessも考慮されるべきと思われた.